Epinak 50mg Injection
Marketer
Nakularch Meditech Pvt. Ltd.
Salt Composition
Epirubicin (50mg)
Overview Epinak 50mg Injection
Epinak 50mg injection treats various hematologic malignancies and cancers affecting the breast, stomach, lungs, ovaries, and soft tissues. It also aids in preventing bladder cancer relapse post-surgery. Administered intravenously by a healthcare professional, it's used alone or in combination chemotherapy regimens, with dosage and frequency determined by your physician based on your condition and potentially adjusted over time. Strict adherence to your doctor's instructions is crucial; incorrect usage or overdosage can lead to severe adverse effects. While therapeutic benefits may take weeks or months to manifest, discontinue use only upon medical advice. Epinak reduces contraceptive efficacy; reliable birth control is advised for both partners throughout treatment. Common side effects include nausea, thrombocytopenia, alopecia, amenorrhea, pyrexia, and dermatitis. Its effect on blood cell counts increases infection risk, potentially life-threatening. Regular blood tests monitoring blood cell levels, renal, hepatic, and cardiac function are essential. Before commencing treatment, disclose any liver or heart conditions, and list all concurrent medications, as interactions may affect Epinak's efficacy or mechanism. Notify your doctor of pregnancy or breastfeeding.
Uses of Epinak 50mg Injection
Malignant neoplasm
Major Benefits of Epinak 50mg Injection:
The medication will be administered by your physician or registered nurse; please refrain from self-medicating.
Common Side effects of Epinak 50mg Injection:
- Low blood platelets
- Nausea
- Hair loss
- Absence of menstrual periods
- Fever
- Anemia (low number of red blood cells)
- Diarrhea
- Weight loss
- Decreased white blood cell count (neutrophils)
- Hot flashes
- Gastrointestinal inflammation
- Rash
- Low energy
- Eye disorder
How to use Epinak 50mg Injection:
Administering this medication will be handled by your physician or registered nurse; patient self-administration is strictly prohibited.
How Epinak 50mg Injection works:
Epinak 50mg Injection is a chemotherapeutic agent used in the treatment of breast cancer. Its mechanism involves inhibiting topoisomerase II, a crucial enzyme in DNA replication within breast cancer cells. This inhibition, coupled with the generation of cytotoxic free radicals, leads to DNA damage, thereby hindering tumor growth and ultimately inducing cell death.
SAFETY ADVICE
AlcoholUNSAFE
Combining Epinak 50mg Injection with alcohol is hazardous.
PregnancyCONSULT YOUR DOCTOR
Administering Epinak 50mg Injection during pregnancy poses a confirmed risk to the fetus. Nevertheless, in exceptional, life-threatening circumstances, a physician might deem its use justified when the potential benefits outweigh the inherent dangers. Always seek medical advice.
Breast feedingUNSAFE
Administering Epinak 50mg Injection while breastfeeding poses a significant risk. Evidence indicates potential harm to the infant due to the medication's toxicity.
DrivingUNSAFE
Administering Epinak 50mg Injection may result in adverse reactions that can compromise driving capabilities. Nausea and vomiting are possible side effects of Epinak 50mg Injection, potentially causing temporary driving impairment.
KidneySAFE IF PRESCRIBED
Epinak 50mg Injection appears safe for individuals with kidney impairment. Current evidence indicates dose modification may be unnecessary; however, physician consultation is recommended. For patients exhibiting serum creatinine exceeding 5 mg/dL, reduced dosages should be explored.
LiverCAUTION
Epinak 50mg Injection requires careful administration for individuals with hepatic impairment. Dosage modification may be necessary. Physician consultation is advised. The use of Epinak 50mg Injection is contraindicated in patients exhibiting severe liver dysfunction.
What if you forget to take Epinak 50mg Injection :
NA
Facts to Know About Epinak 50mg Injection
| Label | Value |
|---|---|
| Chemical Type | Anthracycline Analog |
| Developing Habits | No. |
| Treatment Category | Cancer Therapeutics |
| Action Class | Cytotoxic alkaloids |
3,018 People bought this recently